Literature DB >> 8040321

Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli.

O Levy1, C E Ooi, J Weiss, R I Lehrer, P Elsbach.   

Abstract

Affinity purification of crude acid extracts of rabbit polymorphonuclear leukocytes using Escherichia coli (J5) as adsorbent yields the bactericidal/permeability-increasing protein (BPI), two 15-kD species (p15s), and the two most potent (cationic) defensin species (neutrophil peptides [NP] -1 and -2). Tested in buffered isotonic medium, the relative antibacterial potency of these proteins against E. coli J5 is BPI (IC50 0.2 nM) > p15A (10 nM) > NP -1 (400 nM). Sublethal doses of p15A or NP-1 can synergize with BPI to decrease the dose required to inhibit the growth of E. coli by up to 50-fold. BPI and p15A display similar features of antibacterial action distinct from defensin NP-1, but NP-1 acts synergistically only with BPI and not with p15A. All aspects of the combined action of BPI and NP-1 resemble those observed with higher concentrations of BPI alone, implying that NP-1 enhances BPI potency. Neither NP-1 nor p15A alter the amount of BPI binding to E. coli but BPI enhances binding of p15A to E. coli, raising the possibility that synergy between these two proteins may occur at least partially at the level of binding. The potent synergistic actions of these proteins can also be demonstrated against serum-resistant clinical isolates of encapsulated E. coli tested in whole blood and plasma ex vivo, suggesting that such combined action may contribute to host defense in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040321      PMCID: PMC296145          DOI: 10.1172/JCI117384

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Human neutrophil azurocidin synergizes with leukocyte elastase and cathepsin G in the killing of Capnocytophaga sputigena.

Authors:  K T Miyasaki; A L Bodeau
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 2.  Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin.

Authors:  P Elsbach; J Weiss
Journal:  Curr Opin Immunol       Date:  1993-02       Impact factor: 7.486

Review 3.  The humoral antibacterial response of Drosophila.

Authors:  J A Hoffmann; C Hetru; J M Reichhart
Journal:  FEBS Lett       Date:  1993-06-28       Impact factor: 4.124

4.  Functional and chemical characterization of Hymenoptaecin, an antibacterial polypeptide that is infection-inducible in the honeybee (Apis mellifera).

Authors:  P Casteels; C Ampe; F Jacobs; P Tempst
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

Review 5.  The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.

Authors:  P Elsbach; J Weiss
Journal:  Immunobiology       Date:  1993-04       Impact factor: 3.144

6.  Characterization of bovine neutrophil antibacterial polypeptides which bind to Escherichia coli.

Authors:  L Litteri; D Romeo
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

Review 7.  Antibiotic peptides and serine protease homologs in human polymorphonuclear leukocytes: defensins and azurocidin.

Authors:  J E Gabay; R P Almeida
Journal:  Curr Opin Immunol       Date:  1993-02       Impact factor: 7.486

Review 8.  Defensins: antimicrobial and cytotoxic peptides of mammalian cells.

Authors:  R I Lehrer; A K Lichtenstein; T Ganz
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

9.  Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis.

Authors:  A V Panyutich; E A Panyutich; V A Krapivin; E A Baturevich; T Ganz
Journal:  J Lab Clin Med       Date:  1993-08

10.  Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine.

Authors:  H G Boman; B Agerberth; A Boman
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

View more
  24 in total

1.  Induction of a rat enteric defensin gene by hemorrhagic shock.

Authors:  M R Condon; A Viera; M D'Alessio; G Diamond
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 2.  A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein.

Authors:  O Levy
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 3.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

4.  Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.

Authors:  L M Madsen; M Inada; J Weiss
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 5.  The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.

Authors:  Hendrik Schultz; Jerrold P Weiss
Journal:  Clin Chim Acta       Date:  2007-07-13       Impact factor: 3.786

Review 6.  Bacteria in the intestine, helpful residents or enemies from within?

Authors:  Geraldine O Canny; Beth A McCormick
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

Review 7.  Antimicrobial peptides: modes of mechanism, modulation of defense responses.

Authors:  Mohammad Rahnamaeian
Journal:  Plant Signal Behav       Date:  2011-09

8.  Synergistic interactions between mammalian antimicrobial defense peptides.

Authors:  H Yan; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

9.  Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.

Authors:  Y Weinrauch; A Foreman; C Shu; K Zarember; O Levy; P Elsbach; J Weiss
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  An enhancer peptide for membrane-disrupting antimicrobial peptides.

Authors:  Satoshi Ueno; Kohtaro Kusaka; Yasushi Tamada; Hong Zhang; Masaomi Minaba; Yusuke Kato
Journal:  BMC Microbiol       Date:  2010-02-15       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.